Evaluation of surgical treatment results in parosteal osteosarcoma

Similar documents
Proximal Tibia Parosteal Osteosarcoma Treated With Total Knee Arthroplasty In A 40 Year Female Patient- A Case Report.

Chondrosarcoma with a late local relapse

Osteosarcoma Arising from Giant Cell Tumor of Bone Ten Years After Primary Surgery: A Case Report and Review of the Literature

Paraosteal Osteosarcoma of Mandible: A Case Report. A Narwal, A Hooda, R Sen, V Singh, A Gupta, S Bala, D Sethi

Clear Cell Chondrosarcoma of the Sacrum

SICOT Online Report E057 Accepted April 23th, in Fibula and Rib

University Journal of Surgery and Surgical Specialities

Disclosures. Giant Cell Rich Tumors of Bone. Outline. The osteoclast. Giant cell rich tumors 5/21/11

SURGICAL MANAGEMENT OF OSTEOGENIC SARCOMA OF THE LOWER LIMB JOSEPH M. LANE, M.D., GERALD ROSEN, M.D.,

Spinal metastasis of intermediate grade chondrosarcoma without pulmonary involvement

Intercalary Femur and Tibia Segmental Allografts Provide an Acceptable Alternative in Reconstructing Tumor Resections

Original article. F. Gherlinzoni, P. Picci, G. Bacci & D. Campanacci

Metastatic Disease of the Proximal Femur

The other bone sarcomas

Radiological appearances of appendicular osteosarcoma: a comprehensive pictorial review

Results of thoracotomy in osteogenic sarcoma

A. Nahal MD,* A. Ajlan MD, T. Alcindor MD, and R. Turcotte MD P A T H O L O G Y ABSTRACT 2. CASE DESCRIPTION KEY WORDS 1.

Ethan M. Braunstein, M.D. 1, Steven A. Goldstein, Ph.D. 2, Janet Ku, M.S. 2, Patrick Smith, M.D. 2, and Larry S. Matthews, M.D. 2

Low-grade surface tumours of bone may

High grade focal areas in low grade central osteosarcoma: high grade or still low grade osteosarcoma?

GIANT CELL-RICH OSTEOSARCOMA: A CASE REPORT

Citation Acta medica Nagasakiensia. 1997, 42

According to the World Health Organization classification

Introduction to Musculoskeletal Tumors. James C. Wittig, MD Orthopedic Oncologist Sarcoma Surgeon

Management of Campanacci type III giant cell tumor

Although second only to myeloma as the most

Bizarre parosteal osteochondromatous proliferation

Bizarre parosteal osteochondromatous proliferation (Nora s lesion) affecting the distal end of the ulna: a case report

BONE TRANSPLANTATION IN LIMB SAVING SURGERIES: THE PHILIPPINE EXPERIENCE

We have studied 560 patients with osteosarcoma of a

Challenges and pitfalls in diagnosis of parosteal Osteosarcoma: a clinicopathologic study of 23 cases

ARTICLE. MR imaging in staging of bone tumors

Grading of Bone Tumors

2. Assessment of interobserver variability and histological parameters to improve. central cartilaginous tumours.

Primary bone tumors > metastases from other sites Primary bone tumors widely range -from benign to malignant. Classified according to the normal cell

Recurrent adamantinoma of the tibia and lymph node metastasis

Functional and oncological outcomes after total claviculectomy for primary malignancy

Response of Osteosarcoma to Chemotherapy in Scotland. Ewan Semple, 5 th Year Medical Student, University of Aberdeen

COPYRIGHT 2004 BY THE JOURNAL OF BONE AND JOINT SURGERY, INCORPORATED

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

Secondary Chondrosarcoma from an Osteochondroma of the Proximal Tibia Involving the Fibula

Surgical Management for Giant Cell Tumor of Bones

Lytic Lesion in the Distal Phalanx of the Hand

PAROSTEAL (JUXTACORTICAL) OSTEOSARCOMA

MARK D. MURPHEY MD, FACR. Physician-in-Chief, AIRP. Chief, Musculoskeletal Imaging

Giant Cell Tumour of the Distal Radius: Wide Resection and Reconstruction by Non-vascularised Proximal Fibular Autograft

Malignant bone tumors. Incidence Myeloma 45% Osteosarcoma 24% Chondrosarcoma 12% Lyphoma 8% Ewing s Sarcoma 7%

Mark D. Murphey, MD, FACR

WHAT IS MDM2? (MDMTWOMICS) MDM2 IN SARCOMAS? (MDMTWOMAS) MDM2MICS? NO CONFLICT OF INTERESTS 5/07/2018 MDM2 IN SOFT TISSUE AND BONE SARCOMAS

Extraskeletal osteosarcoma: analysis of outcome of a rare neoplasm

LAC + USC.

Delayed presentation of osteochondroma at superior angle of scapula- a case report

Case Report Chondroblastoma of the Knee Treated with Resection and Osteochondral Allograft Reconstruction

Effective local and systemic therapy is necessary for the cure of Ewing tumor Most chemotherapy regimens are a combination of cyclophosphamide,

Clinical assessment of the relative lengths of the fingers of the human hand

Case 8 Soft tissue swelling

Laura M. Fayad, MD. Associate Professor of Radiology, Orthopaedic Surgery & Oncology The Johns Hopkins University

Extraskeletal Osteosarcoma: Clinico-pathologic Features and Results of Multimodal Management

Surgical treatment is decisive for outcome in chondrosarcoma of the chest wall: A population-based Scandinavian Sarcoma Group study of 106 patients

A case of parosteal osteosarcoma with a rare complication of myositis ossificans

Bone Tumours - a synopsis. Dr Zena Slim SpR in Histopathology QAH 2009

Author's response to reviews

Functional Outcome Study of Mega-Endoprosthetic Reconstruction in Limbs With Bone Tumour Surgery

Review Article Chondrosarcoma of the Mobile Spine and Sacrum

Symptoms and signs associated with benign and malignant proximal fibular tumors: a clinicopathological analysis of 52 cases

came from a carcinoma and in 12 from a sarcoma. Ninety lesions were intrapulmonary and the as the chest wall and pleura. Details of the primary

Diaphyseal sclerotic osteosarcoma presenting as a pathological fracture

JMSCR Vol 3 Issue 11 Page November 2015

Evaluation of Bone tumors with Magnetic Resonance Imaging and correlation with surgical and gross pathological findings.

Case report. Open Access. Abstract

Musculoskeletal Sarcomas

S known to occur as a complication of therapeutic

Acta Medica Okayama. Malignant fibrous histiocytoma with skeletal involvement. Hideo Takechi Kohji Taguchi OCTOBER 1978

Chondroblastoma of bone

Bony metastases following complete resection of periosteal chondrosarcoma

Intracapsular and para- articular chondroma of knee: a report of four cases and review of the literature

Review Article The Identification of Prognostic Factors and Survival Statistics of Conventional Central Chondrosarcoma

Dedifferentiated parosteal osteosarcoma of the maxilla: a case report and review of the literature

Intraosseous hemangioma is an uncommon benign

Endovascular and surgical treatment of giant pelvic tumor

Pleomorphic carcinoma of the lung: which CT findings predict poor prognosis?

Therapy Related Changes in Osteosarcoma and Ewing Sarcoma of Bone

ISSN: DISTRIBUTION OF BONE AND CARTILAGINOUS TUMORS IN PEDIATRIC AGE GROUP IN WESTERN UTTAR-PRADESH: AN EVALUATIVE STUDY

Soft-tissue Recurrence of Giant Cell tumor of Bone Associated with Pulmonary Metastases.

CASE PRESENTATION. Dr. Faseeh Shahab PGY3 Orthopaedic Resident, Khyber Teaching Hospital, Peshawar, PAKISTAN

Custom Mega Prosthesis in Metachronous Osteosarcoma

JMSCR Vol 06 Issue 12 Page December 2018

A REVIEW OF THE BEHAVIOUR OF CHONDROSARCOMA OF BONE

Monophasic Synovial Carcinoma of knee joint- A Case Report and Review of Literature

Reconstructive treatment following resection of high-grade soft-tissue sarcomas of the lower limb

Non-monomelic synchronous primary multicentric chondrosarcoma : A case report

Management of infected custom mega prosthesis by Ilizarov method

MRI XR, CT, NM. Principal Modality (2): Case Report # 2. Date accepted: 15 March 2013

Long-Term Survivals of Stage IIB Osteosarcoma: A 20-Year Experience in a Single Institution

Title: An intramedullary free vascularized fibular graft combined with pasteurized

We studied the CT and MR scans, and the

Diagnosis and staging of osteosarcoma

Cerebral metastases from malignant brous histiocytoma of bone

Bursa Formation and Synovial Chondrometaplasia Associated with Osteochondromas

Transcription:

Original Research Medical Journal of the Islamic Republic of Iran.Vol. 24, No. 1, May, 2010. pp. 11-16. Downloaded from mjiri.iums.ac.ir at 1:31 IRDT on Wednesday September 19th 2018 Evaluation of surgical treatment results in parosteal osteosarcoma Sam Haji-Aliloo Sami, 1 MD, Mikail Alt Jafarbay, 2 MD, Mehdi Ramezan Shirazi, 3 MD. Department of Orthopedic Surgery, Shafa Yahyaian Hospital, Baharestan Sq., Tehran, Iran. Abstract Background: Parosteal osteosarcoma is rare low-grade malignancy which arises on the surface of the metaphysis of long bones; it has a low propensity to metastasize. Different surgical treatment options including marginal resection, wide resection and amputation were recommended for the tumor. The purpose of the study was to assess the results of different surgical treatment of the lesion. Methods: Thirty five consecutive patients with parosteal osteosarcoma were managed with four surgical techniques (Marginal resection, wide resection and prosthesis, wide resection and allograft application, and amputation) between 1378-1387, and the results were retrospectively reviewed. The mean age of the patients when the surgery was performed was 30.37 (range, eleven to seventy one years), and the mean duration of postoperative follow - up was 51 months (range, eight months to ten years) Results: The mean time between the onset of symptoms and initial physician encounter was 15.98 months (range, 1.5 months to 60 months). None of the patients had metastasis preoperatively while three pulmonary metastases were detected postoperatively. Six patients had regional tumor recurrence postoperatively. The mean time of the recurrence postoperatively was 18.8 months (range, nine months to forty eight months). Three of thirty five patients assessed in the study died of pulmonary metastasis. All had dedifferentiated grading with different staging (Two patients had a stage of IIB and one with IIA). Medullary invasion was seen in one of them. One of the three patients was treated with Indomethacin for two years due to the misdiagnosis of myositis ossificans. Conclusion: Wide resection of parosteal osteosarcoma produces a satisfactory long - term out come. However, individually - based treatment should be selected for each patient with parosteal osteosarcoma. Keyword: parosteal osteosarcoma, treatment,outcome Introduction Parosteal osteosarcoma is a rare low grade tumor that arises from the surface of metaphysis of long bones [1]. The lesion has a peculiar tendency to occur as an ossified mass on the posterior aspect of the distal femur and proximal tibia [4]. Other locations such as the radius or the ulna are very rare [6,7]. It was described for the 1st time by Geschickter and Copeland in 1951 [2,3]. Patients with parosteal osteosarcoma usually have a long history of painless swelling [5]. The highest rate of prevalence is reported in 1. Associate Professor; Iran University of Medical Sciences, Tehran, Iran. 2. Orthopedic surgeon 3. Corresponding Author, Resident of Orthopedic Surgery, Shafa Yahyaian Hospital, Baharestan Sq., Tehran, Iran. Tel: +98 912 1875903. E- mail: Mehdi.shirazi@yahoo.co.uk

Downloaded from mjiri.iums.ac.ir at 1:31 IRDT on Wednesday September 19th 2018 the 3rd and 4th decade of life with a slight female predominance [6,7]. The radiologic features include a densely ossified mass which its density of the periphery is less than that of the center [8]. Histologically, similar to low - grade intramedullary osteosarcoma, parosteal osteosarcoma consists of slightly atypical spindle cells producing slightly irregular osseous trabeculae. The most important prognostic factor at the time of diagnosis of osteosarcomas including parosteal subtype is the extent of disease [1]. Whether medullary invasion with regard to the prognosis is of significance is discussed controversially in the literature. Unni et al.; Farmlett and Fishman [6] concluded that invasion makes the prognosis poor while Ahuja et al. [2] postulated that medullary involvement has no influence on the prognosis of patients with lower grade but worsens prognosis in those with higher grade. Several types of treatment options including marginal resection, wide resection and amputation were recommended in the literature which each of them has advantages and potential pitfalls. The purpose of the study was to evaluate the treatment outcome of patients with parosteal osteosarcoma referring to three selected hospitals between 2000-2009. Methods We reviewed the results in thirty five consecutive patients with parosteal osteosarcoma (Table 1) who had been managed with one of four techniques (thirty two patients were treated with wide resection and allograft application Evaluation of surgical treatment results in... with internal fixation (plating); three cases had wide resection and prosthesis application; marginal resection and amputation were done in three and four patients respectively). The mean age of the patients when the surgery was performed was 30.37 years (range, eleven to seventy one years). Fifteen patients were female and twenty were male. All patients had an established parosteal osteosarcoma confirmed by demographic findings, radiological characteristics and histopathological reports. The most common site for the tumor was distal portion of the femur detected in twenty one patients while ulna, distal tibia and Ilium involvement were the least sites found in three patients (table 1). The left sided involvement was seen in eleven patients and the right in ten. Parosteal osteosarcomas were classified with use of Enneking system which includes three distinct staging of the lesion. In order to determine the stage of the tumor, through tumor work-up including relevant x-rays, chest CT, whole body scan, MRI of the involved part and also assessment of histopathology sample of the lesion was performed. Twenty seven patients had low grade, intracompartmental lesion without any metastasis (Stage IA). Five parosteal osteosarcomas developed as a low grade extracompartmental one with no metastasis (Stage IB). High grade tumors developed in three patients including intracompartmentally and two cases extracompartmentally (Stage IIA, IIB respectively). No regional and distant metastases were found in patients of our study at the time of diagnosis (Stage III). Anteroposterior and lateral plain x-rays were Table 1.Illustration of the anatomical location of the tumor. 12 MJIRI.Vol. 24, No.1, May 2010, pp. 11-16

S. Haji-aliloo Sami, et al. a b c Downloaded from mjiri.iums.ac.ir at 1:31 IRDT on Wednesday September 19th 2018 made regularly postoperatively. All patients were examined by the senior author at the time of the most recent follow - up. Particular attention was paid to the range of motion of the involved joint and clinical symptoms related to regional recurrence of the tumor. The mean duration of follow - up after performing surgery was 51 months (range, eight months to 10 years). Three patients died of pulmonary metastasis at the time of the latest follow - up. MJIRI.Vol. 24, No.1, May 2010, pp. 11-16 d Fig. 1- A 22 year old male patient with a low grade (Stage IA)parosteal osteosarcoma treated with wide resection, allograft application and internal fixation.c and d, post operative X - rays. a, b and c:preoperative x-rays and coronal MRI view of the lesion showing the tumor in the right distal tibia. d and e: Post operative X - rays showing wide resection, allograft application and internal fixation of the tumor. Table 2. Number of patients with different complications. 13 e Results Twenty three patients referred to our three selected hospitals with the clinical complaint of swelling while pain and range of motion limitation were chief complaints in nine and three cases respectively. The mean time between the onset of symptoms and initial physician encounter was 15.98 months (range, 1.5 months to 60 months). In contrast to the previous series, twenty of thirty five patients in the study were male but similar to others [6,7], twenty six of them were in 3rd and 4th decades. None of the patients had metastasis preoperatively while three pulmonary metastases were detected postoperatively. On the basis of radio-

Evaluation of surgical treatment results in... a b Downloaded from mjiri.iums.ac.ir at 1:31 IRDT on Wednesday September 19th 2018 c e f d Fig. 2. A patient with a dedifferentiated parosteal osteosarcoma of the right distal femur treated with wide resection and prosthesis application. He died three years postoperatively due to regional recurrence. a: Preoperative anteroposterior (on the left) and lateral (on the right) radiographs of the lesion on the posterior aspect of the right knee. b: Preoperative sagittal MRI of the tumor showing the lesion on the posterior aspect of the knee with medullary involvement. c& d: Sections of the tumor showing a neoplastic lesion composed of sheets of mesenchymal tumoral cells with hyperchromic nuclei which produced matrix in the form of bone trabecula, osteoid and hyaline cartilage. Fibro-osseous areas composed of fibroblastic spindle cells with mild atypia. The arrow on the left shows osteoid production while the one on the right reveals mesenchymal tumor cells. e& f: Postoperative anteroposterior (on the left) and lateral (on the right) radiographs showing wide resection and prosthesis application of the tumor. logical findings, one patient had medullary invasion. Seven patients were treated with two surgeries: Two because of nonunion; one because of plate breakage; three due to inadequate marginal resection and one because of regional recurrence fourteen months postoperatively. The latter had above knee amputation (Table 2). 14 MJIRI.Vol. 24, No.1, May 2010, pp. 11-16

Downloaded from mjiri.iums.ac.ir at 1:31 IRDT on Wednesday September 19th 2018 S. Haji-aliloo Sami, et al. Six patients had regional tumor recurrence postoperatively. The mean time of the recurrence was 18.8 months (range, nine months to forty eight months). The 1st was a seventy one year old female patient with a stage of IIB and dedifferentiated grade of parosteal osteosarcoma. Fourteen months postoperatively, tumor recurrence occurred treated with an above knee amputation. The patient died of pulmonary metastasis five months post amputation. Three patients with a low grade (Stage IA) parosteal osteosarcoma were treated with marginal resection in other centers. Due to regional recurrence, wide resection with allograft application and internal fixation was done in our center. The 5th case of local recurrence was a forty year old male patient with a low grade (Stage IB) tumor treated with marginal resection. The patient did not accept any other surgery at all. Interestingly, he was alive fifty one months after the time of diagnosis of the recurrence. The 6th case was a 24 year old male patient with a dedifferentiated grade (Stage IIB) parosteal osteosarcoma who had wide resection. He died of regional recurrence three years postoperatively. Three of thirty five patients assessed in the study died of pulmonary metastasis. All had dedifferentiated grading (Table 3) with different staging (Two patients had a stage of IIB and one with IIA). Medullary invasion was seen in one of them. One of the three patients was treated with Indomethacin for two years due to the misdiagnosis of myositis ossificans. At the latest follow - up examination, six patients had no full range of motion that were treated with wide resection technique. Postoperatively, infection was found in one patient whereas screw, plate and allograft breakage was detected in 4 patients (Table 2). Discussion Currently, three surgical methods (wide resection, marginal resection and amputation) are being used. The current technique of wide resection and allograft or prosthesis application Table 3. Number of patient died with regard to their grading. has been well understood and several authors have reported success in clinical outcome [10,11]. In our study, wide resection and allograft application with internal fixation (plating) was the most common technique applied. It has a high rate of reliability of tumor recurrence and metastasis prevention. However, there are many potential pitfalls. As being large at the time of diagnosis and proximity of the tumor to the relevant neurovascular components at distal femur, making a wide free margin is difficult. Therefore, in practice, this type of surgery has a high rate of morbidity. In our series, all six patients with no full range of motion were treated with the technique. Concerning those treated by wide resection with prosthesis application, one of three patients had dedifferentiated distal femur parosteal osteosarcoma (Stage IIA). This patient had local recurrence and pulmonary metastasis six months later and died. The second patient did not have full range of motion at the latest follow up (ROM = 10-100). The third case had no complication in the last visit. As the number of patients treated with this technique was low, statistically it is not possible to assess the efficacy of the treatment and compare to other methods of wide resection. The worse course of the first patient's disease is due to the grade of the tumor rather than the method of treatment. Numerous authors have reported on the use of marginal resection in the treatment of parosteal osteosarcoma. Eight of twenty one patients treated with marginal resection were reported on by Hans et al. [11]. They applied the treatment option if there was the possibility of joint surface preservation. Two of these eight MJIRI.Vol. 24, No.1, May 2010, pp. 11-16 15

Downloaded from mjiri.iums.ac.ir at 1:31 IRDT on Wednesday September 19th 2018 patients had the tumor recurrence. In an attempt to decrease the rate of recurrence, attention should be paid to the following factors: 1. Marginal resection - As a treatment option in our study, all four patients experienced the recurrence. 2. Grading of the tumor - Grading is the most significant prognostic factor in parosteal osteosarcoma [10,12,13]. In our series, two of four patients with regional recurrence had dedifferentiated parosteal osteosarcoma. 3. Medullary involvement - In some series [4,6,9], it was found that medullary invasion has a negative influence on prognosis. However, no correlation between medullary involvement and local recurrence or metastasis has been reported on by Okada et al [5] and Vander Walt et al. [14]. In our study, one patient had medullary invasion that died of pulmonary metastasis. Differential diagnoses of the subtype of osteosarcoma are myositis ossificans and osteochondroma [1]. These diagnoses should be considered in radiological and histopathological assessment as one of thirty five patients in the study was treated with Indomethacin for two years with the diagnosis of myositis ossificans and unfortunately died of pulmonary metastasis. Bertoni et al. reported patients with dedifferentiated parosteal osteosarcoma should be treated with wide resection with or without chemotherapy. In these high grade sarcomas, adjuvant chemotherapy often has a role in the prevention of distant metastasis [15]. Five of thirty five patients had chemotherapy in our series. Two of them who had dedifferentiated tumor died. Perhaps, chemotherapy should be added to the standard surgical treatment in order to improve prognosis in those with dedifferentiated parosteal osteosarcoma. Conclusion As wide resection of parosteal osteosarcoma Evaluation of surgical treatment results in... is accompanied with a low rate of regional recurrence and metastasis, it produces a satisfactory long - term out come. However, individually - based treatment option should be selected for each patient with parosteal Osteosarcoma. References 1. Canale T, Beaty JH. Campbell's operative orthopaedics. 11th edition. 2008; p. 904. 2. Ahuja SC, Villacin AB, Smith J, Bullough PG, Huvos AG, Marcove RC. Juxtacortical (parosteal) Osteogenic sarcoma: Histological grading and prognosis. J bone Joint Surg Am 1977 59: 632-47. 3. Picci P, Campanacci M, Baci G, Capanna R, Ayula A. Medullary involvement in parosteal osteosarcoma. A case report. J Bone Joint Surg Am 1987; 69: 131-6. 4. Schajowicz F, McGuire MH, Araujo ES, Muscolo DL, Gitelis S. Osteosarcomas arising on the surface of long bones. J Bone Joint Surg Am 1988; 70: 555-64. 5. Okada K, Frassica FJ, Sim FH et al. Parosteal Osteosarcoma: A clinicopathological study. J bone Joint Surg 1994; 76: 366-378. 6. Farmlett E, Fishmann EK, Case report 300. Skelet Radiol 1985; 13: 89-93. 7. Luck JR, Luck JV, Schwimm CP. Parosteal osteosarcoma: A treatment - oriented study. Clin Orthop Relat Res 1980; 153: 92-105. 8. Edeiken-Monroe B, Edeiken J, Jacobson HG. Osteosarcoma: Semin Roentgenol 1989; 24: 153-173. 9. Unni KK, Dahlin DD, Beabout JW, Ivin JC. Parosteal osteogenic sarcoma: Cancer 1976; 37: 2466-2475. 10. Ritschl P, Wurnig C, Lechner G, Roessner A. Parosteal osteosarcoma: 2-23 year follow - up of 33 patients. Acta Orthop Scand 1991; 62: 195-200. 11. Han I, O JH, Na YG, Moon KG, Kim HS. Clinical outcome of parosteal osteosarcoma. J Surg Oncol 2008; 97: 146-49. 12. Campanacci M, Picci P, Gherlinzoni F, Guerra A, Bertoni F, Neff R. Parosteal osteosarcoma. J Bone Joint Surg Br 1984; 66: 313-21. 13. Wold LE, Unni KK, Beabout JW, Sim FH, Dahlin DC. Dedifferentiated parosteal osteosarcoma. J Bone Joint Surg Am 1984; 66: 53-9. 14. Van derwalt JD, Ryan JF. Parosteal osteogenic sarcoma of the hand. Histopathology 1990; 16: 75-78. 15. Bertoni F, Bacchini P, Staals EL, Davidovitz P. Dedifferentiated parosteal osteosarcoma: The experience of the Rizzoli Institute. Cancer 2005; 103: 2373-82. 16 MJIRI.Vol. 24, No.1, May 2010, pp. 11-16